Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > ps..

<< Previous

Bullboard Posts

Next >>

Comment by BlueFrankyon Oct 31, 2024 2:17pm

161 Views

Post# 36291025

RE:RE:RE:RE:RE:RE:ps..

Perhaps another question might be: do TLT lawyers consider news from the FDA on a pre-BTD application to be legally material and if not for instance, would it be more advantageous to release said "non-essential" news before or after a PP?

It would also be interesting to know what other applicants have done with pre-BTD news insofar as dissemination (or not) to shareholders?

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario